1. Home
  2. HIMX vs VCEL Comparison

HIMX vs VCEL Comparison

Compare HIMX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIMX
  • VCEL
  • Stock Information
  • Founded
  • HIMX 2001
  • VCEL 1989
  • Country
  • HIMX Taiwan
  • VCEL United States
  • Employees
  • HIMX N/A
  • VCEL N/A
  • Industry
  • HIMX Semiconductors
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HIMX Technology
  • VCEL Health Care
  • Exchange
  • HIMX Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • HIMX 1.5B
  • VCEL 1.6B
  • IPO Year
  • HIMX 2006
  • VCEL 1997
  • Fundamental
  • Price
  • HIMX $9.04
  • VCEL $33.98
  • Analyst Decision
  • HIMX Buy
  • VCEL Strong Buy
  • Analyst Count
  • HIMX 1
  • VCEL 6
  • Target Price
  • HIMX $15.00
  • VCEL $60.60
  • AVG Volume (30 Days)
  • HIMX 982.8K
  • VCEL 898.6K
  • Earning Date
  • HIMX 11-06-2025
  • VCEL 11-06-2025
  • Dividend Yield
  • HIMX 4.12%
  • VCEL N/A
  • EPS Growth
  • HIMX N/A
  • VCEL 2045.40
  • EPS
  • HIMX 0.42
  • VCEL 0.13
  • Revenue
  • HIMX $889,561,000.00
  • VCEL $249,119,000.00
  • Revenue This Year
  • HIMX N/A
  • VCEL $18.35
  • Revenue Next Year
  • HIMX $16.64
  • VCEL $22.26
  • P/E Ratio
  • HIMX $21.61
  • VCEL $248.22
  • Revenue Growth
  • HIMX N/A
  • VCEL 16.13
  • 52 Week Low
  • HIMX $5.12
  • VCEL $29.24
  • 52 Week High
  • HIMX $13.91
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • HIMX 60.12
  • VCEL 53.55
  • Support Level
  • HIMX $8.55
  • VCEL $30.51
  • Resistance Level
  • HIMX $8.84
  • VCEL $32.05
  • Average True Range (ATR)
  • HIMX 0.31
  • VCEL 1.24
  • MACD
  • HIMX 0.04
  • VCEL 0.54
  • Stochastic Oscillator
  • HIMX 68.79
  • VCEL 99.37

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: